PATENT CLAIM ANALYSIS

Application Number: 16173114
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["424", "136100"]

Abstract:
Multispecific proteins that bind and specifically redirect NK cells to lyse a target cell of interest are provided without non-specific activation of NK cells in absence of target cells. The proteins have utility in the treatment of disease, notably cancer or infectious disease.

Claim (Index 94):
The multispecific antigen binding protein of  claim 79 , wherein the monovalent NKp46 ABD comprises V H  and V L  domain polypeptides selected from the group consisting of:\n (a) the V H  and V L  domains of SEQ ID NOS: 3 and 4 (NKp46-1); (b) the V H  and V L  domains of SEQ ID NOS: 5 and 6 (NKp46-2); (c) the V H  and V L  domains of SEQ ID NOS: 7 and 8 (NKp46-3); (d) the V H  and V L  domains of SEQ ID NOS: 9 and 10 (NKp46-4); (e) the V H  and V L  domains of SEQ ID NOS: 11 and 12 (NKp46-6); and (f) the V H  and V L  domains of SEQ ID NOS: 13 and 14 (NKp46-9).

Metadata:
- Claim Count in Document: 59.0
- Percentile: 97.0
- Lexical Diversity: 1.31429
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15190337', '15321650', '14691509', '16041309', '11921123']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8155662626889837
- 35 USC 102 Novelty (BERT): 0.7075460027363826
- Combined Prediction Score: 0.8047642366937235
- Mean Citation Score: 535.968584
- Max Citation Score: 918.7742
- Similarity Product: 724.1109228990077

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test